Publishing research using ab120335? Please let us know so that we can cite the reference in this datasheet.

ab120335 has been referenced in 9 publications.

  • Mancini SJ  et al. Canagliflozin inhibits interleukin-1ß-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms. Sci Rep 8:5276 (2018). PubMed: 29588466
  • Dite TA  et al. The autophagy initiator ULK1 sensitizes AMPK to allosteric drugs. Nat Commun 8:571 (2017). PubMed: 28924239
  • Bizjak M  et al. Combined treatment with Metformin and 2-deoxy glucose induces detachment of viable MDA-MB-231 breast cancer cells in vitro. Sci Rep 7:1761 (2017). Functional Studies ; Human . PubMed: 28496098
  • Webb TJ  et al. Alterations in cellular metabolism modulate CD1d-mediated NKT-cell responses. Pathog Dis 74:N/A (2016). PubMed: 27297969
  • Head SA  et al. Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells. Proc Natl Acad Sci U S A 112:E7276-85 (2015). PubMed: 26655341
  • Yan Y  et al. SUMOylation of AMPKa1 by PIAS4 specifically regulates mTORC1 signalling. Nat Commun 6:8979 (2015). PubMed: 26616021
  • Vincent EE  et al. Differential effects of AMPK agonists on cell growth and metabolism. Oncogene : (2014). PubMed: 25241895
  • Chen Z  et al. Promotion of adiponectin multimerization by emodin, a novel AMPK activator with PPAR?-agonist activity. J Cell Biochem : (2012). PubMed: 22730200
  • Galic S  et al. Hematopoietic AMPK ß1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. J Clin Invest 121:4903-15 (2011). PubMed: 22080866

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

Sign up